Skip to content

Clinical trials

Phase 2 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2 Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20055
20064
20072
20084
20096
201010
20114
20124
20134
20147
20152
20163
20172
20181
20197
20207
20218
20226
20238
20242
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated21
Unknown status16
Recruiting15
Withdrawn6
Not yet recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
Amgen6
GlaxoSmithKline6
M.D. Anderson Cancer Center6
Memorial Sloan Kettering Cancer Center5
Fudan University3
Novartis Pharmaceuticals3
Peking University People's Hospital3
Shandong University3
Centre Hospitalier Universitaire de Saint Etienne2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia117
Anemia12
Neutropenia12
Anemia, Aplastic11
Myelodysplastic Syndromes11
Purpura, Thrombocytopenic, Idiopathic10
Autoimmune Diseases8
Leukemia7
Primary Myelofibrosis7
Hematologic Diseases6

Trials

Showing 26 to 50 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.